메뉴 건너뛰기
Archives of Disease in Childhood
Volumn 95, Issue 3, 2010, Pages 237-239
Which medications effectively reduce pubertal gynaecomastia?
Author keywords

[No Author keywords available]
Indexed keywords

ANASTROZOLE; ANDROGEN; CLOMIFENE; DANAZOL; ESTROGEN; PLACEBO; RALOXIFENE; TAMOXIFEN; TESTOLACTONE; ANTIESTROGEN; AROMATASE INHIBITOR; NITRILE; TRIAZOLE DERIVATIVE;
EID: 77949879586     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.176768     Document Type: Note
Times cited : (10)
References (9)
  • 1
    • 3242738579 scopus 로고    scopus 로고
    • Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia
    • Lawrence SE, Faught KA, Vethamuthu J, et al. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 2004;145:71-6.
    • (2004) J Pediatr , vol.145 , pp. 71-76
    • Lawrence, S.E.1    Faught, K.A.2    Vethamuthu, J.3
  • 3
    • 46049119228 scopus 로고    scopus 로고
    • Long-term follow-up of tamoxifen treatment in adolescents with gynecomastia
    • Derman O, Kanbur N, Kilic I, et al. Long-term follow-up of tamoxifen treatment in adolescents with gynecomastia. J Pediatr Endocrinol Metab 2008;21:449-54.
    • (2008) J Pediatr Endocrinol Metab , vol.21 , pp. 449-454
    • Derman, O.1    Kanbur, N.2    Kilic, I.3
  • 4
    • 0023447884 scopus 로고
    • Treatment of marked gynecomastia in puberty with tamoxifen]
    • König R, Schönberger W, Neumann P, et al. [Treatment of marked gynecomastia in puberty with tamoxifen]. Klin Padiatr 1987;199:389-91.
    • (1987) Klin Padiatr , vol.199 , pp. 389-391
    • König, R.1    Schönberger, W.2    Neumann, P.3
  • 5
    • 4544284481 scopus 로고    scopus 로고
    • Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: A randomized, double-blind, placebo-controlled trial
    • Plourde PV, Reiter EO, Jou HC, et al. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2004;89:4428-33.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 4428-4433
    • Plourde, P.V.1    Reiter, E.O.2    Jou, H.C.3
  • 6
    • 4644304161 scopus 로고    scopus 로고
    • Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole
    • Riepe FG, Baus I, Wiest S, et al. Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole. Horm Res 2004;62:113-18.
    • (2004) Horm Res , vol.62 , pp. 113-118
    • Riepe, F.G.1    Baus, I.2    Wiest, S.3
  • 7
    • 0041632421 scopus 로고    scopus 로고
    • Endocrine treatment of physiological gynaecomastia
    • Khan HN, Blamey RW. Endocrine treatment of physiological gynaecomastia. BMJ 2003;327:301-2.
    • (2003) BMJ , vol.327 , pp. 301-302
    • Khan, H.N.1    Blamey, R.W.2
  • 8
    • 0032839420 scopus 로고    scopus 로고
    • Indications for and results of surgical therapy for male gynecomastia
    • Colombo-Benkmann M, Buse B, Stern J, et al. Indications for and results of surgical therapy for male gynecomastia. Am J Surg 1999;178:60-3.
    • (1999) Am J Surg , vol.178 , pp. 60-63
    • Colombo-Benkmann, M.1    Buse, B.2    Stern, J.3
  • 9
    • 0242542209 scopus 로고    scopus 로고
    • Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynaecomastia and breast pain
    • Saltzstein D, Cantwell A, Seiber P, et al. Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynaecomastia and breast pain. Br J Urol Int 2009;90(Suppl 2):120-1.
    • (2009) Br J Urol Int , vol.90 , Issue.SUPPL. 2 , pp. 120-121
    • Saltzstein, D.1    Cantwell, A.2    Seiber, P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.